Virtual Library

Start Your Search

  • ELCC 2018

    The 8th European Lung Cancer Conference

    Access to all presentations that took place at ELCC 2018 in Geneva, Switzerland

    Presentation Date(s):  
    • Apr 11 - 14, 2018
    • Total Presentations: 407

Filter Results:

Show Only Available Presentations

  • +

    Optimizing targeted therapy in lung cancer

    • Type: Poster Discussion session
    • Presentations: 9
    • Moderators:F. Cappuzzo
    • Coordinates: 4/12/2018, 16:45 - 17:45, Room W
    • +

      3PD - Co-targeting PIM1 or Src to overcome the limits of single MET inhibition

      16:45 - 16:45  |  Presenter: I. Attili

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    Poster Display session (Friday)

    • Type: Poster Display session
    • Presentations: 197
    • Coordinates: 4/13/2018, 12:30 - 13:00, Hall 1
    • +

      24P - Proviral integration site for Moloney murine leukemia virus-1 (PIM-1) inhibition with AZD1208 to prevent resistance to osimertinib in EGFR mutant NSCLC

      12:30 - 12:30  |  Presenter: J. Bracht

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      25P - A non-pathway-specific approach in EGFR and KRAS mutant or squamous cell histology non-small cell lung cancer (NSCLC)

      12:30 - 12:30  |  Presenter: M. Ito

      • Abstract

      Loading...

    • +

      58P - Co-treatment of trametinib (MEK inhibitor) with TPX-0005 (Src/FAK/JAK2 inhibitor) synergistic in KRAS mutant NSCLC cell lines and CDCP1 acts as a biomarker in KRAS mutant patients (p)

      12:30 - 12:30  |  Presenter: C. Codony-Servat

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      66P - PALB2 mRNA expression as a predictive marker in advanced non-small cell lung cancer (NSCLC) patients (p) treated with docetaxel-cisplatin

      12:30 - 12:30  |  Presenter: N. Karachaliou

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      198TiP - Afatinib plus EGF pathway targeting immunization (EGF-PTI) as first line therapy for EGFR mutant NSCLC: The EPICAL study

      12:50 - 12:50  |  Presenter: N. Karachaliou

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.